Annual Working Capital
-$5.90 M
-$207.00 K-3.64%
December 31, 2023
Summary
- As of February 8, 2025, BCLI annual working capital is -$5.90 million, with the most recent change of -$207.00 thousand (-3.64%) on December 31, 2023.
- During the last 3 years, BCLI annual working capital has fallen by -$37.91 million (-118.44%).
- BCLI annual working capital is now -118.44% below its all-time high of $32.01 million, reached on December 31, 2020.
Performance
BCLI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$6.72 M
-$2.84 M-73.37%
September 30, 2024
Summary
- As of February 8, 2025, BCLI quarterly working capital is -$6.72 million, with the most recent change of -$2.84 million (-73.37%) on September 30, 2024.
- Over the past year, BCLI quarterly working capital has dropped by -$2.84 million (-73.37%).
- BCLI quarterly working capital is now -120.46% below its all-time high of $32.84 million, reached on March 31, 2021.
Performance
BCLI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BCLI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.6% | -73.4% |
| 3 y3 years | -118.4% | -73.4% |
| 5 y5 years | -245.4% | -73.4% |
BCLI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -134.8% | at low | -139.6% | +10.3% |
| 5 y | 5-year | -118.4% | +58.7% | -120.5% | +53.0% |
| alltime | all time | -118.4% | +58.7% | -120.5% | +53.0% |
Brainstorm Cell Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$6.72 M(+73.4%) |
| Jun 2024 | - | -$3.88 M(-30.5%) |
| Mar 2024 | - | -$5.57 M(-5.6%) |
| Dec 2023 | -$5.90 M(+3.6%) | -$5.90 M(+23.4%) |
| Sep 2023 | - | -$4.78 M(-26.2%) |
| Jun 2023 | - | -$6.48 M(-13.5%) |
| Mar 2023 | - | -$7.49 M(+31.6%) |
| Dec 2022 | -$5.69 M(-133.6%) | -$5.69 M(+293.8%) |
| Sep 2022 | - | -$1.45 M(-129.2%) |
| Jun 2022 | - | $4.96 M(-58.3%) |
| Mar 2022 | - | $11.89 M(-29.9%) |
| Dec 2021 | $16.96 M(-47.0%) | $16.96 M(-23.2%) |
| Sep 2021 | - | $22.10 M(-18.5%) |
| Jun 2021 | - | $27.13 M(-17.4%) |
| Mar 2021 | - | $32.84 M(+2.6%) |
| Dec 2020 | $32.01 M(-323.9%) | $32.01 M(+33.9%) |
| Sep 2020 | - | $23.91 M(+207.0%) |
| Jun 2020 | - | $7.79 M(+12.0%) |
| Mar 2020 | - | $6.95 M(-148.6%) |
| Dec 2019 | -$14.29 M(-452.2%) | -$14.29 M(+96.2%) |
| Sep 2019 | - | -$7.29 M(+45.5%) |
| Jun 2019 | - | -$5.01 M(+2145.7%) |
| Mar 2019 | - | -$223.00 K(-105.5%) |
| Dec 2018 | $4.06 M(-0.5%) | $4.06 M(-54.0%) |
| Sep 2018 | - | $8.83 M(-22.7%) |
| Jun 2018 | - | $11.42 M(+399.4%) |
| Mar 2018 | - | $2.29 M(-44.0%) |
| Dec 2017 | $4.08 M(-57.4%) | $4.08 M(-15.2%) |
| Sep 2017 | - | $4.81 M(-31.0%) |
| Jun 2017 | - | $6.97 M(-12.2%) |
| Mar 2017 | - | $7.94 M(-17.2%) |
| Dec 2016 | $9.58 M(-30.8%) | $9.58 M(-6.0%) |
| Sep 2016 | - | $10.19 M(-11.6%) |
| Jun 2016 | - | $11.53 M(-6.0%) |
| Mar 2016 | - | $12.27 M(-11.3%) |
| Dec 2015 | $13.84 M(+114.0%) | $13.84 M(-9.3%) |
| Sep 2015 | - | $15.25 M(-13.0%) |
| Jun 2015 | - | $17.54 M(-9.4%) |
| Mar 2015 | - | $19.35 M(+199.3%) |
| Dec 2014 | $6.46 M(+107.6%) | $6.46 M(-25.8%) |
| Sep 2014 | - | $8.71 M(-16.4%) |
| Jun 2014 | - | $10.43 M(+364.2%) |
| Mar 2014 | - | $2.25 M(-27.9%) |
| Dec 2013 | $3.11 M | $3.11 M(-27.3%) |
| Sep 2013 | - | $4.29 M(+105.1%) |
| Jun 2013 | - | $2.09 M(-35.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $3.24 M(-12.9%) |
| Dec 2012 | $3.72 M(+218.0%) | $3.72 M(-11.2%) |
| Sep 2012 | - | $4.19 M(-8644.9%) |
| Jun 2012 | - | -$49.00 K(-110.1%) |
| Mar 2012 | - | $485.00 K(-58.5%) |
| Dec 2011 | $1.17 M(-238.5%) | $1.17 M(-41.2%) |
| Sep 2011 | - | $1.99 M(+7.1%) |
| Jun 2011 | - | $1.86 M(-18.3%) |
| Mar 2011 | - | $2.27 M(-369.5%) |
| Dec 2010 | -$844.00 K(-63.3%) | -$844.00 K(-18.8%) |
| Sep 2010 | - | -$1.04 M(+11.1%) |
| Jun 2010 | - | -$936.00 K(+87.6%) |
| Mar 2010 | - | -$499.00 K(-78.3%) |
| Dec 2009 | -$2.30 M(-17.8%) | -$2.30 M(-27.6%) |
| Sep 2009 | - | -$3.18 M(+8.2%) |
| Jun 2009 | - | -$2.94 M(-1.0%) |
| Mar 2009 | - | -$2.96 M(+5.9%) |
| Dec 2008 | -$2.80 M(-5.7%) | -$2.80 M(+9.6%) |
| Sep 2008 | - | -$2.56 M(+5.8%) |
| Jun 2008 | - | -$2.41 M(-27.4%) |
| Mar 2008 | - | -$3.32 M(+11.9%) |
| Dec 2007 | -$2.97 M(+25.7%) | -$2.97 M(+27.5%) |
| Sep 2007 | - | -$2.33 M(-33.9%) |
| Jun 2007 | - | -$3.52 M(+16.1%) |
| Mar 2007 | - | -$3.04 M(+54.6%) |
| Dec 2006 | -$2.36 M(+236.5%) | - |
| Sep 2006 | - | -$1.97 M(+51.8%) |
| Jun 2006 | - | -$1.29 M(+84.3%) |
| Mar 2006 | - | -$702.30 K(+20.2%) |
| Mar 2006 | -$702.30 K(-247.5%) | - |
| Dec 2005 | - | -$584.30 K(+180.4%) |
| Sep 2005 | - | -$208.40 K(-986.8%) |
| Jun 2005 | - | $23.50 K(-95.1%) |
| Mar 2005 | $476.10 K(>+9900.0%) | $476.10 K(+140.1%) |
| Dec 2004 | - | $198.30 K(+426.0%) |
| Sep 2004 | - | $37.70 K(-40.2%) |
| Jun 2004 | - | $63.00 K(>+9900.0%) |
| Mar 2004 | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2003 | - | -$33.70 K(+17.0%) |
| Sep 2003 | - | -$28.80 K(+65.5%) |
| Jun 2003 | - | -$17.40 K(+17.6%) |
| Mar 2003 | -$14.80 K(-158.3%) | -$14.80 K(-268.2%) |
| Dec 2002 | - | $8800.00(-50.6%) |
| Sep 2002 | - | $17.80 K(-40.9%) |
| Jun 2002 | - | $30.10 K |
| Mar 2002 | $25.40 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual working capital?
- What is the all time high annual working capital for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual working capital year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly working capital year-on-year change?
What is Brainstorm Cell Therapeutics annual working capital?
The current annual working capital of BCLI is -$5.90 M
What is the all time high annual working capital for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual working capital is $32.01 M
What is Brainstorm Cell Therapeutics annual working capital year-on-year change?
Over the past year, BCLI annual working capital has changed by -$207.00 K (-3.64%)
What is Brainstorm Cell Therapeutics quarterly working capital?
The current quarterly working capital of BCLI is -$6.72 M
What is the all time high quarterly working capital for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly working capital is $32.84 M
What is Brainstorm Cell Therapeutics quarterly working capital year-on-year change?
Over the past year, BCLI quarterly working capital has changed by -$2.84 M (-73.37%)